- Home
- GNFT vs AGD Comparison
GNFT vs AGD Comparison
Compare GNFT & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- AGD
- Stock Information
- Founded
- GNFT 1999
- AGD 2006
- Country
- GNFT France
- AGD United Kingdom
- Employees
- GNFT N/A
- AGD N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- AGD Trusts Except Educational Religious and Charitable
- Sector
- GNFT Health Care
- AGD Finance
- Exchange
- GNFT Nasdaq
- AGD Nasdaq
- Market Cap
- GNFT 249.0M
- AGD 253.4M
- IPO Year
- GNFT 2019
- AGD N/A
- Fundamental
- Price
- GNFT $6.06
- AGD $10.51
- Analyst Decision
- GNFT Strong Buy
- AGD
- Analyst Count
- GNFT 1
- AGD 0
- Target Price
- GNFT $13.00
- AGD N/A
- AVG Volume (30 Days)
- GNFT 26.3K
- AGD 61.2K
- Earning Date
- GNFT 09-19-2024
- AGD 01-01-0001
- Dividend Yield
- GNFT N/A
- AGD 8.13%
- EPS Growth
- GNFT N/A
- AGD N/A
- EPS
- GNFT 0.47
- AGD N/A
- Revenue
- GNFT $86,225,222.00
- AGD N/A
- Revenue This Year
- GNFT $155.44
- AGD N/A
- Revenue Next Year
- GNFT N/A
- AGD N/A
- P/E Ratio
- GNFT $12.34
- AGD N/A
- Revenue Growth
- GNFT 175.45
- AGD N/A
- 52 Week Low
- GNFT $2.97
- AGD $8.20
- 52 Week High
- GNFT $6.08
- AGD $9.78
- Technical
- Relative Strength Index (RSI)
- GNFT 69.91
- AGD 61.10
- Support Level
- GNFT $5.41
- AGD $10.35
- Resistance Level
- GNFT $5.84
- AGD $10.52
- Average True Range (ATR)
- GNFT 0.30
- AGD 0.08
- MACD
- GNFT 0.04
- AGD -0.00
- Stochastic Oscillator
- GNFT 98.03
- AGD 62.16
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current dividend income. The Fund also focuses on the long-term growth of capital as a secondary investment objective.